BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21447370)

  • 21. Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor.
    Cucciolla V; Borriello A; Criscuolo M; Sinisi AA; Bencivenga D; Tramontano A; Scudieri AC; Oliva A; Zappia V; Della Ragione F
    Carcinogenesis; 2008 Mar; 29(3):560-7. PubMed ID: 18204075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C/EBPbeta Promotes transition from proliferation to hypertrophic differentiation of chondrocytes through transactivation of p57.
    Hirata M; Kugimiya F; Fukai A; Ohba S; Kawamura N; Ogasawara T; Kawasaki Y; Saito T; Yano F; Ikeda T; Nakamura K; Chung UI; Kawaguchi H
    PLoS One; 2009; 4(2):e4543. PubMed ID: 19229324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional regulation of
    Rossi MN; Andresini O; Matteini F; Maione R
    Front Biosci (Landmark Ed); 2018 Jan; 23(1):83-108. PubMed ID: 28930539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype.
    Li Y; Nagai H; Ohno T; Yuge M; Hatano S; Ito E; Mori N; Saito H; Kinoshita T
    Blood; 2002 Oct; 100(7):2572-7. PubMed ID: 12239171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of P57(kip2) and cyslinE proteins in human pancreatic cancer.
    Yue H; Yu J; Zhao X; Song F; Feng X
    Chin Med J (Engl); 2003 Jun; 116(6):944-6. PubMed ID: 12877813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p57KIP2 immunohistochemistry in early molar pregnancies: emphasis on its complementary role in the differential diagnosis of hydropic abortuses.
    Merchant SH; Amin MB; Viswanatha DS; Malhotra RK; Moehlenkamp C; Joste NE
    Hum Pathol; 2005 Feb; 36(2):180-6. PubMed ID: 15754295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells.
    Yang X; Karuturi RK; Sun F; Aau M; Yu K; Shao R; Miller LD; Tan PB; Yu Q
    PLoS One; 2009; 4(4):e5011. PubMed ID: 19340297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer.
    Puhalla H; Wrba F; Kandioler D; Lehnert M; Huynh A; Gruenberger T; Tamandl D; Filipits M
    Anticancer Res; 2007; 27(3B):1679-84. PubMed ID: 17595796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p57(Kip2) regulates progenitor cell proliferation and amacrine interneuron development in the mouse retina.
    Dyer MA; Cepko CL
    Development; 2000 Aug; 127(16):3593-605. PubMed ID: 10903183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased expression of decorin and p57(KIP2) correlates with poor survival and lymphatic metastasis in lung cancer patients.
    Biaoxue R; Xiguang C; Hua L; Hui M; Shuanying Y; Wei Z; Wenli S; Jie D
    Int J Biol Markers; 2011; 26(1):9-21. PubMed ID: 21360479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of p57kip2, Rb protein and PCNA and their relationships with clinicopathology in human pancreatic cancer.
    Yue H; Na YL; Feng XL; Ma SR; Song FL; Yang B
    World J Gastroenterol; 2003 Feb; 9(2):377-80. PubMed ID: 12532471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p57(KIP2) control of actin cytoskeleton dynamics is responsible for its mitochondrial pro-apoptotic effect.
    Kavanagh E; Vlachos P; Emourgeon V; Rodhe J; Joseph B
    Cell Death Dis; 2012 May; 3(5):e311. PubMed ID: 22592318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of p57
    Takahashi K; Yoneyama Y; Koizumi N; Utoguchi N; Kanayama N; Higashi N
    Placenta; 2021 Jan; 104():168-178. PubMed ID: 33360007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues.
    Fan GK; Chen J; Ping F; Geng Y
    Oral Oncol; 2006 Feb; 42(2):147-53. PubMed ID: 16246616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cross-talk between DNA methylation and H3 lysine 9 dimethylation at the KvDMR1 region controls the induction of Cdkn1c in muscle cells.
    Andresini O; Ciotti A; Rossi MN; Battistelli C; Carbone M; Maione R
    Epigenetics; 2016 Nov; 11(11):791-803. PubMed ID: 27611768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver maturation deficiency in p57(Kip2)-/- mice occurs in a hepatocytic p57(Kip2) expression-independent manner.
    Yanagida A; Chikada H; Ito K; Umino A; Kato-Itoh M; Yamazaki Y; Sato H; Kobayashi T; Yamaguchi T; Nakayama KI; Nakauchi H; Kamiya A
    Dev Biol; 2015 Nov; 407(2):331-43. PubMed ID: 26165599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional upregulation of p57 (Kip2) by the cyclin-dependent kinase inhibitor BMS-387032 is E2F dependent and serves as a negative feedback loop limiting cytotoxicity.
    Ma Y; Cress WD
    Oncogene; 2007 May; 26(24):3532-40. PubMed ID: 17173074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Periodic expression of the cyclin-dependent kinase inhibitor p57(Kip2) in trophoblast giant cells defines a G2-like gap phase of the endocycle.
    Hattori N; Davies TC; Anson-Cartwright L; Cross JC
    Mol Biol Cell; 2000 Mar; 11(3):1037-45. PubMed ID: 10712518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigen p57/Kip2 as a potential negative regulator of human astrocytoma growth.
    Akaishi K; Nakayama J; Sakai K; Kobayashi T; Rutka JT
    J Clin Neurosci; 2009 Dec; 16(12):1615-8. PubMed ID: 19822429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-21 inhibits p57Kip2 expression in prostate cancer.
    Mishra S; Lin CL; Huang TH; Bouamar H; Sun LZ
    Mol Cancer; 2014 Sep; 13():212. PubMed ID: 25216674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.